Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Talking about medication.

Robert Alan Glick1, Steven P Roose

  • 1Columbia University Center for Psychoanalytic Training and Research, USA. rag4@columbia.edu

Journal of the American Psychoanalytic Association
|October 3, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Moderators of antidepressant augmentation versus switch in the OPTIMUM randomised controlled trial.

The British journal of psychiatry : the journal of mental science·2025
Same author

Treatment of Cognitive Impairment in Late Life Depression.

The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry·2024
Same author

Poor Sleep is Common in Treatment-Resistant Late-life Depression and Associated With Poorer Antidepressant Response: Findings From the OPTIMUM Clinical Trial.

The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry·2024
Same author

Relationship between Patient Health Questionnaire (PHQ-9) and Montgomery-Asberg Depression Rating Scale (MADRS) total scores in older adults with major depressive disorder: An analysis of the OPTIMUM clinical trial.

Journal of affective disorders·2024
Same author

Alcohol and substance use in older adults with treatment-resistant depression.

International journal of geriatric psychiatry·2024
Same author

The Columbia Academy for Psychoanalytic Educators: A Pilot Program for Developing Analysts and Supervisors of Analytic Candidates.

Journal of the American Psychoanalytic Association·2024
Same journal

Why I Write: My Journey.

Journal of the American Psychoanalytic Association·2026
Same journal

Book Essay: Perspectives on Aging: Countering Ageism in Psychoanalytic ThoughtMidlife: Humanity's Secret Weapon. By <i>Andrew Jamieson</i>. Burneside, UK: Notting Hill Editions, 2022, 144 pp., $19.95 hardcover.Psychoanalysis of Aging and Maturity: The Concept of Maturescence. By <i>Guillermo Julio Montero</i>. Abington, UK: Routledge, 2020, 144 pp., $34.49 paperback.Blooming in December: Psychodynamic Psychotherapy With Older Adults. By <i>Amy Schaffer</i>. Abington, UK: Routledge, 2021, 119 pp., $27.24 paperback.Breaking the Age Code: How Your Beliefs About Aging Determine How Long and Well You Live. By <i>Becca Levy</i>. New York: HarperCollins, 2022, 294 pp., $15.99 paperback.Life Reimagined: The Science, Art, and Opportunity of Midlife. By <i>Barbara Bradley Hagerty</i>. New York: Riverhead, 2016, 451 pp., $24.00 paperback.

Journal of the American Psychoanalytic Association·2026
Same journal

From the Editors.

Journal of the American Psychoanalytic Association·2026
Same journal

Essay: Marianne Goldberger: A Mold-Breaking Psychoanalyst in Her Time, and Importantly, for Ours.

Journal of the American Psychoanalytic Association·2026
Same journal

Why I Podcast.

Journal of the American Psychoanalytic Association·2026
Same journal

The Humanistic Basis of Psychoanalytic Practice.

Journal of the American Psychoanalytic Association·2026
See all related articles

Psychotropic medication side effects can trigger analyst anxiety, potentially disrupting psychoanalysis. Effective combined treatment requires analysts to understand both analytic and pharmacological models.

Area of Science:

  • Psychiatry
  • Psychoanalysis
  • Clinical Psychology

Background:

  • Increasing use of psychotropic medications alongside psychoanalysis presents unique clinical challenges.
  • Patient complaints about medication side effects are common in combined treatments.
  • These complaints can impact the psychoanalytic process.

Purpose of the Study:

  • To examine the countertransference challenges faced by psychoanalysts when patients report medication side effects.
  • To explore how these side effects can lead to the abandonment of transference analysis.
  • To identify strategies for maintaining effective psychoanalytic treatment in combined settings.

Main Methods:

  • Analysis of clinical scenarios involving psychotropic medication and psychoanalysis.

Related Experiment Videos

  • Examination of specific countertransference anxieties and fantasies experienced by analysts.
  • Discussion of the reasons for analysts suspending curiosity and openness.

    • Main Results:

    • Medication side effects can evoke specific countertransference anxieties in analysts.
    • These anxieties may lead analysts to abandon transference analysis.
    • Analysts may suspend their natural curiosity and openness due to these challenges.

    Conclusions:

    • Effective psychoanalytic treatment in combined settings requires analysts to be "bilingual."
    • Analysts must integrate both analytic and pharmacological perspectives.
    • Maintaining openness and curiosity is crucial for successful outcomes.